Correlation Between Nkarta and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nkarta and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Nkarta and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Syndax Pharmaceuticals.
Diversification Opportunities for Nkarta and Syndax Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Nkarta and Syndax is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Nkarta i.e., Nkarta and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nkarta and Syndax Pharmaceuticals
Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the Syndax Pharmaceuticals. In addition to that, Nkarta is 1.32 times more volatile than Syndax Pharmaceuticals. It trades about -0.26 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.12 per unit of volatility. If you would invest 1,424 in Syndax Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 104.00 from holding Syndax Pharmaceuticals or generate 7.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Nkarta Inc vs. Syndax Pharmaceuticals
Performance |
Timeline |
Nkarta Inc |
Syndax Pharmaceuticals |
Nkarta and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nkarta and Syndax Pharmaceuticals
The main advantage of trading using opposite Nkarta and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.Nkarta vs. Monte Rosa Therapeutics | ||
Nkarta vs. Lyell Immunopharma | ||
Nkarta vs. Generation Bio Co | ||
Nkarta vs. Sana Biotechnology |
Syndax Pharmaceuticals vs. Cogent Biosciences | ||
Syndax Pharmaceuticals vs. Cullinan Oncology LLC | ||
Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | ||
Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |